Sheppard Mullin Attorneys Named “Life Science Stars” in LMG Life Sciences 2024
The 2024 edition of LMG Life Sciences named five Sheppard Mullin partners “Life Science Stars” across its FDA, Corporate and Intellectual Property categories, including:
- Dominick DiSabatino, FDA: Pharmaceutical Rising Star
- Jeffrey Fessler, Corporate
- Scott Liebman, FDA: Pharmaceutical and FDA: Medical Device
- Lorna Tanner, Intellectual Property (Patent Strategy & Management)
- Daniel Yannuzzi, Intellectual Property (Patent Prosecution; Patent Strategy & Management; and General Patent Litigation)
LMG Life Sciences is the only legal ranking directory to identify the leading law firms and individuals in each practice area of the life sciences sector through deep analysis of the business and legal developments in the sector. The annual rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement. From regulatory approval or patent filing to collaborative transactions or product liabilities, legal practitioners play an important role in guiding a product through its life cycle. The guide recognizes that products born from biotechnology, pharmaceutical and medical device companies also demand a sophisticated scientific understanding.